# ImmunityBio, Inc.: Form 8-K, filed Dec 11, 2024

- Company: [ImmunityBio, Inc.](/companies/ibrx.md) (CIK 1326110)
- Form: 8-K
- Filed: 2024-12-11
- Accepted by EDGAR: Dec 11, 2024, 07:46 ET
- Period: 2024-12-10
- Accession: 0001193125-24-274871
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326110/000119312524274871/d875134d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326110/000119312524274871/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326110/000119312524274871/d875134d8k.htm

Filed Dec 11, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-274871. Last ingested by Listed: Nov 9, 2026, 17:45 ET. No prices; not investment advice.